Q32 Bio Inc. (QTTB) Net income 2017–2025
Q32 Bio Inc. (QTTB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$29.8MFY2025 · since FY2017: -$30.0M → $29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.8M | +162.5% |
| FY2024 | -$47.7M | +11.2% |
| FY2023 | -$53.7M | -973.8% |
| FY2022 | -$5.0M | +94.8% |
| FY2021 | -$95.8M | +25.6% |
| FY2020 | -$128.7M | -23.8% |
| FY2019 | -$103.9M | -87.0% |
| FY2018 | -$55.6M | -85.3% |
| FY2017 | -$30.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net marginQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating marginQTTB Operating cash flowQTTB Free cash flowQTTB Capital expendituresQTTB Return on equityQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Total liabilitiesQTTB Shareholders’ equityQTTB overview →